Genesee Cancer and Blood Disease Treatment Center — Flint, Michigan

Genesee Cancer and Blood Disease Treatment Center is a clinical research site located in Flint, Michigan, United States 48503.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Genesee Cancer and Blood Disease Treatment Center has participated in 83 clinical trials with 43 currently active.

Therapeutic areas: Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8.

Sponsors: SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group, Wake Forest University Health Sciences.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Genesee Cancer and Blood Disease Treatment Center?

Genesee Cancer and Blood Disease Treatment Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Genesee Cancer and Blood Disease Treatment Center conducted?

Genesee Cancer and Blood Disease Treatment Center has 83 clinical trials on record, with 43 currently active. Their work covers Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8.

Is Genesee Cancer and Blood Disease Treatment Center accredited by Crixeo Health?

Genesee Cancer and Blood Disease Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Genesee Cancer and Blood Disease Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.